Reverse Transcription PCR for Other Myeloid Leukemia Transcripts
Reference20 articles.
1. Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA;Duployez;Am J Hematol.,2014
2. High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome;Krauth;Leukemia.,2014
3. Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations;Micol;Blood.,2014
4. Core-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy;Solh;Am J Hematol.,2014
5. Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease;Hoyos;Eur J Haematol.,2013